Standout Papers

Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell A... 2006 2026 2012 2019 1.2k
  1. Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5 (2006)
    Li Liu, Yichen Cao et al. Cancer Research

Citation Impact

1 by Nobel laureates 2 from Science/Nature 68 standout
Sub-graph 1 of 19

Citing Papers

Cell death
2024 Standout
Cutaneous melanoma
2023 Standout
2 intermediate papers

Works of Christopher Carter being referenced

Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5
2006 Standout

Author Peers

Author SPS Communication CNC Molecular Biology Hepatology Last Decade Papers Cites
Christopher Carter 42 8 4 634 423 19 1.5k
Juan Cabrera‐Luque 199 11 308
Rolf Roland Weber 2 32 31 822
Roberto Flore 7 11 10 472
Vincenzo Dell’Acqua 96 2 8 423
Sheila MacNeil 18 16 358

All Works

Loading papers...

Rankless by CCL
2026